AnalystEdge
Sign inGet started
← All stocks

TNGX — Tango Therapeutics

Median target
$40
calls from the last 12 months
Implied return
+72.6%
median target vs. price
Coverage
12 analysts · 13 calls
updated in the last 12 months
Consensus
10/2/0+10 net
Buy / Hold / Sell

Which analysts are behind TNGX's consensus?

See every current rating, price target and the analysts' track records for Tango Therapeutics — plus the full analyst rankings, firm analytics and screener.

Unlock with PremiumSign in

The consensus above reflects 12 analysts with calls on TNGX updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

TNGX elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-11-02InsidersNewcomb JessicaPrincipal Accounting OffInsider sale5.6K sh @ $22.28 · planned trade$124K
2026-11-02InsidersCrystal AdamPresident, R&DInsider sale3.9K sh @ $22.26 · planned trade$87K
2026-11-02InsidersNewcomb JessicaPrincipal Accounting OffInsider sale1.5K sh @ $22.98 · planned trade$34K
2026-11-02InsidersCrystal AdamPresident, R&DInsider sale1.1K sh @ $22.99 · planned trade$25K
2026-10-01InsidersCrystal AdamPresident, R&DInsider sale26.4K sh @ $24.45 · planned trade$646K
2026-10-01InsidersCrystal AdamPresident, R&DInsider sale600 sh @ $25.32 · planned trade$15K
2026-09-22InsidersNewcomb JessicaOfficerInsider sale5.1K sh @ $23.97 · planned trade$122K
2026-09-22InsidersNewcomb JessicaOfficerInsider sale2.4K sh @ $25.17 · planned trade$60K
2026-09-22InsidersNewcomb JessicaOfficerInsider sale700 sh @ $22.80 · planned trade$16K

More: insider activity · executive branch · trending